New Age Alpha Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$76.3K Buy
8,511
+276
+3% +$2.47K ﹤0.01% 742
2025
Q1
$61.8K Buy
+8,235
New +$61.8K ﹤0.01% 792